AstraZeneca_NN
Code_NN
of_PIN
Conduct_NN
157_CD
ASTRAZENECA_NN
CODE_NN
OF_PIN
CONDUCT_NN
INTRODUCTION_NOMZ
situations_NOMZ
should_NEMD
be_VB [PASS]
sought_VBN
from_PIN
management_NOMZ
._.
AstraZeneca_NN
funds_NN
will_PRMD
not_XX0
be_VB [PASS]
used_VBN
in_PIN
We_FPP1
are_VPRT [PASS]
committed_VBN
to_TO
dealing_VBG
with_PIN
all_QUAN
our_FPP1
In_CONJ
addition_NULL
,_,
Legal_NN
Department_NOMZ
and_PHC
Group_NN
payments_NOMZ
,_,
direct_JJ
or_CC
indirect_JJ
,_,
to_PIN
government_NOMZ
stakeholders_NN
with_PIN
the_DT
highest_JJ
ethical_JJ
standards_NN
,_,
Internal_NN
Audit_NN
are_VPRT [BEMA]
available_PRED
on_PIN
a_DT
confidential_JJ
officials_NN
,_,
people_NN
participating_VBG [WZPRES]
in_PIN
government_NOMZ
integrity_NOMZ
and_CC
as_IN
responsible_JJ
corporate_JJ
citizens_NN
._.
basis_NN
as_IN
independent_JJ
sources_NN
of_PIN
advice_NN
._.
bodies_NN
,_,
employees_NN
of_PIN
state_NN
organizations_NOMZ
or_CC
The_DT
trust_NN
and_PHC
confidence_NN
of_PIN
all_QUAN
our_FPP1
stakeholders_NN
,_,
representatives_NN
of_PIN
political_JJ
parties_NN
,_,
for_PIN
unlawful_JJ
together_RB
with_PIN
our_FPP1
reputation_NOMZ
,_,
are_VPRT [BEMA]
among_PIN
the_DT
It_PIT
is_VPRT [BEMA]
the_DT
responsibility_NOMZ
of_PIN
each_QUAN
employee_NN
to_TO
or_CC
improper_JJ
purposes_NN
._.
most_EMPH
valuable_JJ
assets_NN
of_PIN
the_DT
Group_NN
._.
Along_IN
with_PIN
report_NN
promptly_RB
any_QUAN
violations_NOMZ
of_PIN
the_DT
Code_NN
our_FPP1
commitment_NOMZ
to_PIN
competitiveness_NOMZ
and_CC
of_PIN
Conduct_NN
of_PIN
which_WDT [PIRE]
they_TPP3
become_VPRT
aware_JJ
._.
Equal_NN
opportunities_NOMZ
performance_NN
,_,
we_FPP1
will_PRMD
continue_VB
to_TO
be_VB [BYPA]
led_VBN
by_PIN
AstraZeneca_NN
assures_VPRT
individual_JJ
employees_NN
All_QUAN
employees_NN
shall_PRMD
be_VB [PASS]
treated_VBN
with_PIN
equal_JJ
our_FPP1
values_NN
to_TO
achieve_VB
sustainable_JJ
success_NN
._.
who_WP
raise_VPRT
issues_NN
that_TOBJ
they_TPP3
will_PRMD
be_VB [PASS]
protected_VBN
respect_NN
and_PHC
dignity_NOMZ
and_CC
shall_PRMD
be_VB [PASS]
provided_VBN
from_PIN
any_QUAN
adverse_JJ
impact_NN
on_PIN
their_TPP3
employment_NOMZ
with_PIN
equality_NOMZ
of_PIN
opportunity_NOMZ
to_TO
develop_VB
Every_QUAN
AstraZeneca_NN
employee_NN
is_VPRT [PASS]
required_VBN [SUAV]
to_PIN
as_CONJ
a_NULL
result_NULL
._.
AstraZeneca_NN
actively_RB
encourages_VPRT
themselves_TPP3
and_CC
their_TPP3
careers_NN
._.
make_VB
a_DT
personal_JJ
commitment_NOMZ
to_TO
follow_VB
the_DT
employees_NN
to_TO
raise_VB
issues_NN
of_PIN
concern_NN
._.
Companys_NN
Code_NN
of_PIN
Conduct_NN
,_,
as_RB
well_RB
as_IN
the_DT
AstraZeneca_NN
is_VPRT
striving_VBG
to_TO
achieve_VB
diversity_NOMZ
detailed_JJ
standards_NN
issued_VBN [WZPAST]
in_PIN
support_NN
of_PIN
it_PIT
,_,
and_ANDC
STANDARDS_NN
OF_PIN
CONDUCT_NN
at_PIN
all_QUAN
levels_NN
of_PIN
the_DT
organization_NOMZ
and_CC
values_VPRT
the_DT
uphold_VB
our_FPP1
commitment_NOMZ
to_PIN
our_FPP1
values_NN
,_,
integrity_NOMZ
Business_NOMZ
practices_NN
individuality_NOMZ
,_,
diversity_NOMZ
and_CC
creative_JJ
potential_NN
and_CC
corporate_JJ
responsibility_NOMZ
._.
AstraZeneca_NN
Companies_NN
,_,
and_ANDC
their_TPP3
employees_NN
,_,
that_THVC
every_QUAN
employee_NN
brings_VPRT
to_PIN
its_PIT
business_NOMZ
must_NEMD
comply_VB
with_PIN
the_DT
laws_NN
of_PIN
all_QUAN
countries_NN
and_CC
supports_VPRT
the_DT
continuous_JJ
development_NOMZ
We_FPP1
are_VPRT [BEMA]
all_QUAN
privileged_JJ
to_TO
work_VB
for_PIN
one_CD
of_PIN
the_DT
best_JJ
in_PIN
which_WDT [PIRE]
they_TPP3
operate_VPRT
,_,
with_PIN
appropriate_JJ
of_PIN
their_TPP3
skills_NN
and_PHC
abilities_NOMZ
._.
companies_NN
in_PIN
the_DT
world_NN
and_CC
must_NEMD
ensure_VB [SUAV] [PRIV] [THATD]
we_FPP1
international_JJ
and_PHC
national_JJ
industry_NN
codes_NN
of_PIN
leave_VPRT
a_DT
lasting_JJ
legacy_NN
._.
Nothing_INPR
not_XX0
the_DT
need_NN
practice_NN
and_CC
with_PIN
the_DT
high_JJ
ethical_JJ
standards_NN
Judgements_NOMZ
about_IN
people_NN
for_PIN
the_DT
purpose_NN
to_TO
meet_VB
targets_NN
,_,
or_CC
direct_JJ
orders_NN
from_PIN
a_DT
specified_VBN
by_PIN
AstraZeneca_NN
._.
of_PIN
recruitment_NOMZ
,_,
development_NOMZ
or_CC
promotion_NOMZ
superior_JJ
should_NEMD [SPAU]
ever_RB
compromise_VB
our_FPP1
shall_PRMD
be_VB [PASS]
made_VBN
solely_RB
on_PIN
the_DT
basis_NN
of_PIN
a_DT
persons_NN
commitment_NOMZ
to_PIN
honesty_NN
and_PHC
integrity_NOMZ
._.
It_PIT
is_VPRT [BEMA]
the_DT
responsibility_NOMZ
of_PIN
all_QUAN
employees_NN
to_PIN
ability_NOMZ
and_PHC
potential_NN
in_PIN
relation_NOMZ
to_PIN
the_DT
needs_NN
of_PIN
ensure_VB [SUAV] [PRIV]
,_,
by_PIN
taking_VBG
advice_NN
where_RB
appropriate_JJ
,_,
the_DT
job_NN
and_CC
shall_PRMD [SPAU]
only_DWNT
take_VB
account_NN
of_PIN
matters_NN
SIR_NN
TOM_NN
MCKILLOP_NN
that_TOBJ
they_TPP3
are_VPRT [BEMA]
fully_AMP
aware_PRED
of_PIN
all_QUAN
relevant_JJ
laws_NN
,_,
relevant_JJ
to_PIN
the_DT
performance_NN
of_PIN
that_DEMO
job_NN
._.
Overall_RB
,_,
Chief_NN
Executive_NN
regulations_NOMZ
,_,
practices_NN
and_PHC
codes_NN
of_PIN
practice_NN
,_,
success_NN
and_PHC
advancement_NOMZ
within_PIN
AstraZeneca_NN
July_NN
2003_CD
particularly_RB
as_IN
they_TPP3
relate_VPRT
to_PIN
their_TPP3
job_NN
._.
shall_PRMD
depend_VB
solely_RB
on_PIN
personal_JJ
ability_NOMZ
,_,
behavior_NN
and_PHC
work_NN
performance_NN
._.
POLICY_NN
Employees_NN
should_NEMD
ensure_VB [SUAV] [PRIV] [THATD]
that_DEMP
,_,
within_PIN
their_TPP3
AstraZeneca_NN
requires_VPRT [SUAV]
its_PIT
companies_NN
,_,
and_ANDC
their_TPP3
sphere_NN
of_PIN
business_NOMZ
activity_NOMZ
,_,
AstraZeneca_NN
In_PIN
some_QUAN
countries_NN
these_DEMO
principles_NN
may_POMD
employees_NN
,_,
to_TO
observe_VB [PRIV]
the_DT
highest_JJ
standards_NN
Companies_NN
carry_VPRT
out_PIN
their_TPP3
contractual_JJ
be_VB [BYPA]
modified_VBN
by_PIN
national_JJ
legal_JJ
requirements_NOMZ
of_PIN
integrity_NOMZ
and_PHC
honesty_NN
and_PHC
act_NN
with_PIN
due_JJ
skill_NN
,_,
obligations_NOMZ
in_PIN
a_DT
proper_JJ
and_PHC
timely_JJ
manner_NN
for_PIN
affirmative_JJ
action_NOMZ
._.
care_NN
,_,
diligence_NN
and_PHC
fairness_NOMZ
in_PIN
the_DT
conduct_NN
and_CC
are_VPRT [BEMA]
not_XX0
in_PIN
breach_NN
of_PIN
contract_NN
._.
To_PIN
this_DEMO
end_NN
all_QUAN
AstraZeneca_NN
Personal_NN
harassment_NOMZ
Companies_NN
,_,
and_ANDC
their_TPP3
employees_NN
,_,
are_VPRT [PASS]
required_VBN [SUAV]
Business_NOMZ
practice_NN
,_,
and_ANDC
what_WP
amounts_NN
Personal_JJ
harassment_NOMZ
,_,
such_JJ
as_IN
verbal_JJ
abuse_NN
to_TO
comply_VB
with_PIN
the_DT
laws_NN
of_PIN
all_QUAN
countries_NN
in_PIN
to_PIN
improper_JJ
conduct_NN
,_,
varies_VPRT
from_PIN
country_NN
or_CC
sexual_JJ
harassment_NOMZ
,_,
of_PIN
any_QUAN
employee_NN
which_WDT [WHOBJ]
they_TPP3
operate_VPRT
and_CC
with_PIN
the_DT
high_JJ
ethical_JJ
to_PIN
country_NN
and_CC
from_PIN
industry_NN
to_PIN
industry_NN
._.
All_QUAN
of_PIN
AstraZeneca_NN
,_,
its_PIT
suppliers_NN
or_CC
customers_NN
standards_NN
detailed_VBN [WZPAST]
by_PIN
AstraZeneca_NN
in_PIN
support_NN
employees_NN
will_PRMD
comply_VB
with_PIN
a_DT
the_DT
high_JJ
ethical_JJ
is_VPRT [BEMA]
unacceptable_PRED
in_PIN
any_QUAN
form_NN
whatsoever_RB
._.
standards_NN
specified_VBN [WZPAST]
by_PIN
AstraZeneca_NN
b_NN
any_QUAN
published_VBN
overall_JJ
AstraZeneca_NN
Code_NN
relating_VBG [WZPRES]
Any_QUAN
person_NN
who_WP [WHSUB]
believes_VPRT [PRIV] [THATD]
they_TPP3
have_VPRT [PEAS]
been_VBN
COMPLIANCE_NN
to_PIN
business_NOMZ
practices_NN
and_PHC
c_NN
any_QUAN
international_JJ
personally_RB
harassed_VBN
should_NEMD
report_VB [PUBV]
the_DT
incident_NN
It_PIT
is_VPRT [BEMA]
the_DT
responsibility_NOMZ
of_PIN
management_NOMZ
to_TO
ensure_VB [SUAV] [PRIV]
and_CC
national_JJ
codes_NN
of_PIN
practice_NN
applicable_JJ
to_TO
and_CC
circumstances_NN
to_PIN
their_TPP3
immediate_JJ
manager_NN
that_TOBJ
the_DT
AstraZeneca_NN
Code_NN
of_PIN
Conduct_NN
and_CC
the_DT
conduct_NN
of_PIN
business_NOMZ
in_PIN
each_QUAN
environment_NOMZ
._.
or_CC
HR_NN
manager_NN
or_CC
other_JJ
senior_JJ
manager_NN
who_WP [WHOBJ]
standards_NN
are_VPRT [PASS]
communicated_VBN
,_,
understood_VBN [PRIV]
will_PRMD
arrange_VB [SUAV]
for_PIN
it_PIT
to_TO
be_VB [PASS]
investigated_VBN
impartially_RB
and_CC
acted_VBD
upon_PIN [STPR]
._.
They_TPP3
are_VPRT [PASS]
required_VBN [SUAV]
to_TO
positively_RB
Gifts_NN
,_,
entertainment_NOMZ
and_CC
personal_JJ
favors_NN
may_POMD
and_CC
confidentially_RB
._.
promote_VB
them_TPP3
by_PIN
personal_JJ
example_NN
and_CC
are_VPRT [SPAU]
only_DWNT
be_VB [PASS]
offered_VBN
to_PIN
a_DT
third_JJ
party_NN
if_COND
modest_JJ
in_PIN
not_XX0
entitled_VBN
to_TO
permit_VB
any_QUAN
exceptions_NOMZ
to_PIN
the_DT
value_NN
and_ANDC
if_COND
they_TPP3
are_VPRT [BEMA]
consistent_PRED
with_PIN
customary_JJ
AstraZeneca_NN
is_VPRT [BEMA]
fully_AMP
supportive_PRED
of_PIN
the_DT
principles_NN
required_VBN [SUAV]
behavior_NN
._.
No_SYNE
gifts_NN
,_,
entertainment_NOMZ
or_CC
set_VBN
forth_RB
in_PIN
the_DT
UN_NN
Declaration_NOMZ
of_PIN
Human_NN
personal_JJ
favor_NN
may_POMD
be_VB [PASS]
offered_VBN
in_PIN
contravention_NOMZ
Rights_NN
._.
These_DEMP
include_VPRT
freedom_NN
from_PIN
torture_VB
All_QUAN
employees_NN
should_NEMD
familiarise_VB
themselves_TPP3
of_PIN
any_QUAN
applicable_JJ
law_NN
or_CC
code_NN
of_PIN
practice_NN
._.
and_ANDC
arbitrary_JJ
arrest_NN
,_,
the_DT
right_NN
to_PIN
a_DT
fair_JJ
trial_NN
and_CC
with_PIN
the_DT
Code_NN
of_PIN
Conduct_NN
and_CC
must_NEMD
comply_VB
equality_NOMZ
before_IN
the_DT
law_NN
._.
Failure_NN
to_TO
act_VB
in_PIN
compliance_NN
with_PIN
the_DT
No_SYNE
employee_NN
should_NEMD
seek_VB
or_CC
accept_VB [PRIV]
a_DT
gift_NN
,_,
Code_NN
will_PRMD
result_VB
in_PIN
appropriate_JJ
disciplinary_JJ
entertainment_NOMZ
or_CC
personal_JJ
favor_NN
which_WDT [WHOBJ]
Political_NN
contributions_NOMZ
action_NOMZ
against_PIN
both_DT
the_DT
employee_NN
committing_VBG [WZPRES]
might_POMD [SPAU]
reasonably_RB
be_VB [PASS]
believed_VBN [PRIV]
to_TO
have_VB
any_QUAN
Any_QUAN
political_JJ
contributions_NOMZ
by_PIN
AstraZeneca_NN
the_DT
breach_NN
and_PHC
others_NN
who_WP [WHSUB]
condone_VPRT
it_PIT
._.
An_DT
offer_NN
of_PIN
Companies_NN
must_NEMD
be_VB [BEMA]
lawful_PRED
and_CC
approved_VBD
entertainment_NOMZ
should_NEMD
not_XX0
be_VB [PASS]
accepted_VBN [PRIV]
unless_COND
under_IN
procedures_NN
laid_VBN
down_RP
by_PIN
the_DT
board_NN
or_CC
The_DT
Standards_NN
set_VBD
out_PIN
in_PIN
the_DT
Code_NN
are_VPRT [BEMA]
general_PRED
the_DT
offer_NN
is_VPRT [BEMA]
within_PIN
the_DT
bounds_NN
of_PIN
accepted_VBN [PRIV]
governing_VBG
body_NN
of_PIN
the_DT
Company_NN
concerned_VBN
._.
and_ANDC
do_VB
not_XX0
address_VB
each_QUAN
and_CC
every_QUAN
situation_NOMZ
business_NOMZ
hospitality_NOMZ
._.
Gifts_NN
which_WDT [WHSUB]
do_VPRT
not_XX0
meet_VB
that_DEMP
may_POMD
confront_VB
employees_NN
in_PIN
markets_NN
around_PLACE
the_DT
above_PLACE
criteria_NN
should_NEMD
be_VB [PASS]
reported_VBN [PUBV]
to_PIN
Approval_NN
should_NEMD
not_XX0
be_VB [PASS]
given_VBN
to_PIN
any_QUAN
political_JJ
the_DT
world_NN
._.
In_PIN
appropriate_JJ
cases_NN
,_,
guidance_NN
management_NOMZ
who_WP [WHSUB]
shall_PRMD
determine_VB [SUAV] [PRIV]
how_RB [WHCL]
they_TPP3
contributions_NOMZ
by_PIN
AstraZeneca_NN
Companies_NN
on_PIN
the_DT
application_NOMZ
of_PIN
the_DT
Code_NN
to_PIN
particular_JJ
shall_PRMD
be_VB [PASS]
dealt_VBN
with_PIN [STPR]
._.
which_WDT [SERE]
,_,
by_PIN
their_TPP3
scale_NN
or_CC
affiliation_NOMZ
,_,
might_POMD
AstraZeneca_NN
Annual_JJ
Report_NN
and_CC
158_CD
Form_NN
20-F_JJ
Information_NOMZ
2005_CD
ASTRAZENECA_NN
CODE_NN
OF_PIN
CONDUCT_NN
CONTINUED_VBD
be_VB [PASS]
seen_VBN [PRIV]
as_IN
excessive_JJ
or_CC
inappropriate_JJ
._.
Property_NN
and_PHC
resources_NN
Records_NN
,_,
disclosures_NN
and_PHC
communications_NOMZ
AstraZenecas_NN
accounting_GER
procedures_NN
require_VPRT [SUAV]
AstraZeneca_NN
resources_NN
should_NEMD
be_VB [PASS]
kept_VBN
AstraZeneca_NN
PLC_NN
and_CC
all_QUAN
AstraZeneca_NN
any_QUAN
political_JJ
contribution_NOMZ
to_TO
be_VB [PASS]
reported_VBN [PUBV]
securely_RB
and_CC
should_NEMD [SPAU]
only_DWNT
be_VB [PASS]
used_VBN
for_PIN
the_DT
Companies_NN
and_CC
their_TPP3
employees_NN
are_VPRT [BEMA]
to_PIN
AstraZeneca_NN
headquarters_NN
as_IN
part_NN
of_PIN
the_DT
proper_JJ
advancement_NOMZ
of_PIN
its_PIT
business_NOMZ
and_CC
required_VBN [SUAV]
to_TO
keep_VB
proper_JJ
accounting_GER
and_CC
annual_JJ
consolidation_NOMZ
of_PIN
results_NN
._.
other_JJ
records_NN
which_WDT [WHSUB]
give_VPRT
a_DT
true_JJ
and_PHC
fair_JJ
view_NN
of_PIN
the_DT
financial_JJ
position_NOMZ
,_,
results_NN
of_PIN
Conflicts_NN
of_PIN
interest_NN
Individuals_NN
expending_VBG [WZPRES]
AstraZeneca_NN
resources_NN
operations_NOMZ
,_,
transactions_NOMZ
,_,
assets_NN
and_PHC
Employees_NN
dealing_VBG [WZPRES]
with_PIN
AstraZenecas_NN
should_NEMD
recognize_VB [PRIV]
that_THVC
they_TPP3
owe_VPRT
a_DT
duty_NN
of_PIN
care_NN
liabilities_NOMZ
so_RB
as_IN
to_TO
enable_VB
the_DT
Company_NN
business_NOMZ
must_NEMD
act_VB
in_PIN
the_DT
best_JJ
interests_NN
to_PIN
the_DT
shareholders_NN
of_PIN
AstraZeneca_NN
,_,
who_WP
to_TO
make_VB
full_JJ
,_,
fair_JJ
,_,
accurate_JJ
,_,
timely_JJ
and_CC
of_PIN
AstraZeneca_NN
and_CC
must_NEMD
disregard_VB
any_QUAN
are_VPRT [BEMA]
its_PIT
ultimate_JJ
owners_NN
._.
Commitments_NOMZ
and_CC
understandable_JJ
disclosures_NN
in_PIN
all_QUAN
reports_NN
personal_JJ
preference_NN
or_CC
advantage_NN
._.
expenditure_NN
should_NEMD [SPAU]
only_DWNT
be_VB [BEMA]
such_PRED
as_IN
could_POMD
it_PIT
is_VPRT [PASS]
required_VBN [SUAV]
to_TO
publish_VB
,_,
file_VB
or_CC
submit_VB [PUBV]
be_VB [PASS]
justified_VBN
to_PIN
shareholders_NN
if_COND
the_DT
facts_NN
were_VBD [BEMA]
to_PIN
shareholders_NN
and_PHC
regulators_NN
and_CC
in_PIN
all_QUAN
Employees_NN
should_NEMD
avoid_VB
entering_VBG
into_PIN
situations_NOMZ
known_VBN [PRIV]
._.
This_DEMP
includes_VPRT
any_QUAN
expenses_NN
claimed_VBD [PUBV]
other_JJ
communications_NOMZ
which_WDT [WHOBJ]
it_PIT
publishes_VPRT
._.
in_PIN
which_WDT [PIRE]
their_TPP3
personal_JJ
,_,
family_NN
or_CC
financial_JJ
and_CC
purchases_NN
made_VBN [WZPAST]
for_PIN
which_WDT [PIRE]
reimbursement_NOMZ
interests_NN
may_POMD
conflict_VB
with_PIN
those_DEMO
of_PIN
AstraZeneca_NN
._.
All_QUAN
accounting_GER
and_CC
other_JJ
records_NN
will_PRMD
be_VB
Where_RB
any_QUAN
potential_JJ
conflict_NN
of_PIN
interest_NN
may_POMD
maintained_VBD [PUBV]
in_PIN
a_DT
manner_NN
that_TSUB
describes_VPRT
and_PHC
arise_VB
,_,
the_DT
employee_NN
shall_PRMD
declare_VB [PUBV]
that_THVC
interest_NN
AstraZeneca_NN
resources_NN
include_VPRT
not_XX0
only_DWNT
documents_NOMZ
accurately_RB
the_DT
Companys_NN
true_JJ
and_CC
seek_VB
advice_NN
from_PIN
senior_JJ
management_NOMZ
._.
tangible_JJ
assets_NN
such_JJ
as_IN
materials_NN
,_,
equipment_NOMZ
financial_JJ
position_NOMZ
and_PHC
results_NN
of_PIN
operations_NOMZ
and_CC
and_CC
cash_NN
,_,
but_CC
also_RB
intangible_JJ
assets_NN
such_PDT
the_DT
true_JJ
nature_NN
of_PIN
its_PIT
business_NOMZ
transactions_NOMZ
,_,
Examples_NN
of_PIN
conflict_NN
to_TO
be_VB [PASS]
declared_VBN [PUBV]
and_CC
as_IN
computer_NN
systems_NN
,_,
trade_NN
secrets_NN
and_PHC
assets_NN
and_PHC
liabilities_NOMZ
._.
Accounting_GER
records_NN
will_PRMD
resolved_VBN [SUAV]
include_VPRT
:_:
confidential_JJ
information_NOMZ
._.
Employees_NN
should_NEMD
be_VB [PASS]
kept_VBN
in_PIN
accordance_NN
with_PIN
AstraZeneca_NN
policies_NN
,_,
observe_VPRT [PRIV]
global_JJ
and_PHC
local_JJ
guidelines_NN
relevant_JJ
accounting_GER
standards_NN
and_CC
appropriate_JJ
Having_VBG
a_DT
family_NN
interest_NN
in_PIN
a_DT
transaction_NOMZ
with_PIN
concerning_VBG
the_DT
classifying_VBG
and_PHC
handling_VBG
of_PIN
generally_RB
accepted_VBN [PRIV]
accounting_GER
principles_NN
._.
AstraZeneca_NN
or_CC
one_CD
of_PIN
its_PIT
subsidiaries_NN
the_DT
documents_NOMZ
and_CC
electronic_JJ
data_NN
._.
The_DT
storage_NN
Company_NN
or_CC
any_QUAN
supplier_NN
or_CC
customer_NN
._.
of_PIN
personal_JJ
data_NN
in_PIN
an_DT
electronic_JJ
medium_NN
may_POMD
Employees_NN
must_NEMD
ensure_VB [SUAV] [PRIV]
that_THVC
all_QUAN
reports_NN
Hiring_GER
of_PIN
a_DT
family_NN
member_NN
in_PIN
any_QUAN
capacity_NOMZ
._.
be_VB [BYPA]
governed_VBN
by_PIN
laws_NN
with_PIN
which_WDT [PIRE]
relevant_JJ
published_VBN
,_,
filed_VBN
or_CC
submitted_VBN [PUBV]
to_PIN
shareholders_NN
Having_VBG [WZPRES]
an_DT
interest_NN
,_,
directly_RB
or_CC
through_PIN
employees_NN
should_NEMD
familiarise_VB
themselves_TPP3
and_CC
regulators_NN
and_CC
all_QUAN
other_JJ
communications_NOMZ
family_NN
,_,
in_PIN
a_DT
competitor_NN
,_,
supplier_NN
or_CC
customer_NN
and_CC
comply_VB
._.
which_WDT [SERE]
are_VPRT [BYPA]
published_VBN
by_PIN
the_DT
Company_NN
are_VPRT [BEMA]
full_PRED
,_,
of_PIN
the_DT
Company_NN
._.
fair_JJ
,_,
accurate_JJ
,_,
timely_JJ
and_PHC
understandable_JJ
:_:
they_TPP3
Having_VBG
an_DT
interest_NN
,_,
directly_RB
or_CC
through_PIN
Information_NOMZ
generated_VBD
within_PIN
AstraZeneca_NN
,_,
must_NEMD
not_XX0
mislead_VB
the_DT
reader_NN
in_PIN
any_QUAN
way_NN
or_CC
omit_VB
family_NN
,_,
in_PIN
an_DT
organization_NOMZ
that_TSUB
has_VPRT
,_,
or_CC
seeks_VPRT
including_VBG
research_NN
and_PHC
development_NOMZ
and_CC
anything_QUPR
necessary_JJ
to_TO
make_VB
them_TPP3
full_JJ
,_,
fair_JJ
and_CC
to_TO
do_VB [PROD]
business_NOMZ
with_PIN
the_DT
Company_NN
._.
manufacturing_VBG
data_NN
,_,
costs_NN
,_,
prices_NN
,_,
sales_NN
,_,
profits_NN
,_,
accurate_JJ
._.
The_DT
Chief_NN
Executive_NN
and_CC
the_DT
Acquiring_VBG
an_DT
interest_NN
in_PIN
property_NN
such_JJ
markets_NN
,_,
customers_NN
and_PHC
methods_NN
of_PIN
doing_VBG [PROD]
Companys_NN
senior_JJ
financial_JJ
officers_NN
have_VPRT
as_IN
real_JJ
estate_NN
,_,
patent_NN
rights_NN
or_CC
securities_NOMZ
business_NOMZ
,_,
is_VPRT [BEMA]
the_DT
property_NN
of_PIN
AstraZeneca_NN
and_CC
a_DT
particular_JJ
responsibility_NOMZ
in_PIN
this_DEMO
regard_NN
._.
where_RB
the_DT
Company_NN
has_VPRT
,_,
or_CC
might_POMD
have_VB
,_,
must_NEMD
not_XX0
,_,
unless_COND
legally_RB
required_VBN [SUAV]
,_,
be_VB [PASS]
disclosed_VBN [PUBV]
an_DT
interest_NN
._.
outside_PLACE
AstraZeneca_NN
without_PIN
proper_JJ
authority_NOMZ
._.
These_DEMO
examples_NN
do_VPRT
not_XX0
extend_VB
to_PIN
normal_JJ
and_CC
Policies_NN
,_,
delegated_VBN
authorities_NOMZ
proper_JJ
financial_JJ
investments_NOMZ
in_PIN
publicly_RB
quoted_VBN
and_PHC
reserved_VBN
powers_NN
companies_NN
._.
AstraZeneca_NN
employees_NN
are_VPRT [PASS]
expected_VBN [PRIV]
to_TO
make_VB
themselves_TPP3
aware_JJ
of_PIN
and_CC
comply_VB
Insider_NN
information_NOMZ
with_PIN
the_DT
letter_NN
and_PHC
spirit_NN
of_PIN
all_QUAN
AstraZeneca_NN
Employees_NN
must_NEMD
not_XX0
use_VB
confidential_JJ
policies_NN
and_CC
with_PIN
the_DT
reserved_VBN
powers_NN
and_PHC
information_NOMZ
obtained_VBN [WZPAST]
through_PIN
their_TPP3
delegated_JJ
authorities_NOMZ
established_VBN [PRIV] [WZPAST]
by_PIN
the_DT
employment_NOMZ
for_PIN
personal_JJ
gain_NN
._.
Copies_NN
of_PIN
these_DEMP
are_VPRT [BEMA]
available_PRED
on_PIN
the_DT
Companys_NN
intranet_NN
site_NN
s._VB
It_PIT
is_VPRT
AstraZeneca_NN
policy_NN
,_,
and_ANDC
in_PIN
certain_JJ
countries_NN
a_DT
legal_JJ
requirement_NOMZ
carrying_VBG [WZPRES]
criminal_JJ
sanctions_NOMZ
,_,
The_DT
freedoms_NN
which_WDT [WHOBJ]
individuals_NN
have_VPRT
to_TO
carry_VB
that_DEMO
employees_NN
in_PIN
possession_NN
of_PIN
confidential_JJ
out_PIN
their_TPP3
jobs_NN
must_NEMD
be_VB [PASS]
exercised_VBN
within_PIN
both_DT
price_NN
sensitive_JJ
information_NOMZ
in_PIN
relation_NOMZ
to_PIN
the_DT
letter_NN
and_PHC
spirit_NN
of_PIN
AstraZeneca_NN
policies_NN
securities_NOMZ
do_VPRT
not_XX0
make_VB
use_NN
of_PIN
such_JJ
information_NOMZ
and_PHC
procedures_NN
,_,
reserved_VBN
powers_NN
and_CC
to_TO
deal_VB
in_PIN
securities_NOMZ
of_PIN
AstraZeneca_NN
or_CC
provide_VB
delegated_JJ
authorities_NOMZ
._.
These_DEMP
are_VPRT [PASS]
designed_VBN
such_JJ
information_NOMZ
to_PIN
third_JJ
parties_NN
for_PIN
that_DEMO
to_TO
empower_VB
people_NN
to_TO
carry_VB
out_PIN
their_TPP3
purpose_NN
._.
The_DT
same_JJ
considerations_NOMZ
apply_VPRT
responsibilities_NOMZ
within_PIN
a_DT
necessary_JJ
framework_NN
in_PIN
relation_NOMZ
to_PIN
confidential_JJ
price_NN
sensitive_JJ
of_PIN
corporate_JJ
control_NN
and_CC
legal_JJ
responsibility_NOMZ
information_NOMZ
relating_VBG [WZPRES]
to_PIN
other_JJ
companies_NN
and_CC
but_CC
are_VPRT
not_XX0
so_EMPH
voluminous_PRED
as_IN
to_TO
prescribe_VB
dealing_VBG
in_PIN
their_TPP3
securities_NOMZ
._.
appropriate_JJ
action_NOMZ
in_PIN
every_QUAN
circumstance_NN
._.
